FDA Inspection 1278341 — Mark L. Freedman, M.D.
The FDA completed an inspection of Mark L. Freedman, M.D. on July 18, 2025 in Scarborough. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 18, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Scarborough (Canada)
Additional Details
Clinical BA/BE